2018 -2020 Director, Immuno-oncology and Cellular Therapy Translational Sciences @
2016 -2018 Principal Scientist, Biomarkers @
2015 -2016 Senior Manager, Diagnostics and Biomarkers @
2014 -2015 Lead Scientist Translational Research @
2014 -2014 Senior Scientist Biomarkers @
2012 -2014 Associate Director, Pharmacology @
2005 -2011 Senior Scientist @
2004 -2004 Scientist @
2002 -2004 Postdoctoral Fellow @
Michelle Blake Education
University of Washington
Ph.D. (Pathology)
1995-2001
California Polytechnic State University-San Luis Obispo
Bachelor of Science (Biochemistry/Microbiology double major)
1989-1993
Michelle Blake Skills
In vivo tumor models
Cell culture
Microarray Analysis
Flow Cytometry
Immunohistochemistry
Animal surgery
Signal Transduction
Apoptosis
Technical Project Leadership
Drug discovery
Gene Expression Profiling
Fluorescence Microscopy
Antibody validation
In Vivo
Antibodies
Conceptual Modeling
Validation
In Vitro
Cell
Pharmacology
Monoclonal Antibodies
Assay Development
Oncology
Drug Development
CRO
Translational Medicine
Clinical Development
Translational Research
Biomarkers
High Throughput Screening
Immunology
Inflammation
ELISA
Cell Biology
Pharmaceutical Industry
Project Management
Biochemistry
CRO Management
Research
Michelle Blake Summary
Michelle Blake, based in Seattle, WA, US, is currently a Vice President, Translational Sciences at Sonoma Biotherapeutics. Michelle Blake brings experience from previous roles at Shape Therapeutics, Inc., Celgene, Juno Therapeutics, Inc. and Seattle Genetics. Michelle Blake holds a 1995 - 2001 Ph.D. in Pathology @ University of Washington. With a robust skill set that includes In vivo tumor models, Cell culture, Microarray Analysis, Flow Cytometry, Immunohistochemistry and more. Michelle Blake has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Michelle Blake?
Find contact details for 700 million professionals.